DCM Shriram Limited
In PositoAI's records, DCM Shriram Limited has had 16 dividends since 2021 (₹64.8 per share in total). Latest dividend: ₹4 per share, ex-date 31 Jul 2026.
Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.
DCM Shriram Limited Dividend History#
| Ex-date | Dividend |
|---|---|
| 2026 | ₹7.6 per share (2 payments) |
| 23 Jan 2026 | ₹3.6 per share |
| 31 Jul 2026 | ₹4 per share |
| 2025 | ₹10.6 per share (3 payments) |
| 24 Jan 2025 | ₹3.6 per share |
| 5 Aug 2025 | ₹3.4 per share |
| 3 Nov 2025 | ₹3.6 per share |
| 2024 | ₹8.6 per share (3 payments) |
| 6 Mar 2024 | ₹4 per share |
| 9 Jul 2024 | ₹2.6 per share |
| 11 Nov 2024 | ₹2 per share |
| 2023 | ₹9.4 per share (2 payments) |
| 1 Feb 2023 | ₹5.8 per share |
| 18 Jul 2023 | ₹3.6 per share |
| 2022 | ₹14.7 per share (3 payments) |
| 24 Jan 2022 | ₹5.2 per share |
| 7 Jul 2022 | ₹4.9 per share |
| 31 Oct 2022 | ₹4.6 per share |
| 2021 | ₹13.9 per share (3 payments) |
| 27 Jan 2021 | ₹5.5 per share |
| 8 Jul 2021 | ₹3.8 per share |
| 26 Oct 2021 | ₹4.6 per share |
Amounts are per share as declared, not adjusted for later bonus issues or splits.
Questions
Does DCM Shriram Limited pay dividends?
Yes. In PositoAI's records (from 2021), DCM Shriram Limited has paid 16 dividends, the latest ₹4 per share with ex-date 31 July 2026.
How much dividend did DCM Shriram Limited pay in 2025?
₹10.6 per share in 2025, in 3 payments.
What is an ex-date and a record date?
To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.
Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.